Liver cancer is a serious disease that often goes unnoticed until it reaches an advanced stage. The most common form is hepatocellular carcinoma (HCC), which accounts for up to 90% of primary liver cancers.

Because HCC is usually found late, researchers are working to find blood-based markers that can detect it earlier. Liver Cancer Serum Samples play a central role in this work.

At Bay Biosciences, we provide human biospecimens that support liver cancer research. These include Liver Cancer Blood Samples, Liver Cancer Plasma Samples, Hepatocellular Carcinoma Serum Samples, and other Liver Cancer Biospecimens.

Understanding Liver Cancer

Liver cancer starts when cells in the liver grow out of control and form a tumor. There are two main groups:

  • Primary liver cancer: This begins in the liver itself. HCC is the most common type. Cholangiocarcinoma, which starts in the bile ducts, is less common.
  • Secondary liver cancer: This spreads to the liver from another organ, such as the colon or breast.

HCC usually develops in a liver that has been damaged for years. 

Chronic inflammation and scarring, called cirrhosis, create the conditions for cancer to grow. 

Researchers rank HCC among the leading causes of cancer deaths worldwide.

This link between long-term liver damage and cancer makes Liver Disease Samples valuable for research. Scientists can compare samples across disease stages to see how the liver changes from inflammation to cancer.

Symptoms of Liver Cancer

Early liver cancer often causes no symptoms. As the tumor grows, patients may notice:

Causes and Risk Factors of Liver Cancer

Several factors raise the risk of liver cancer:

  • Chronic hepatitis B or C infection: These viruses cause long-term liver inflammation.
  • Cirrhosis: Scarring from any cause is the strongest risk factor for HCC.
  • Heavy alcohol use: Alcohol damages liver cells over time.
  • Metabolic dysfunction-associated steatotic liver disease (MASLD): Fat build-up in the liver is a growing cause, linked to obesity and type 2 diabetes.
  • Aflatoxin exposure: This toxin comes from mold on stored grains and nuts.
  • Inherited liver conditions such as Hemochromatosis. 

Diagnosis of Liver Cancer

Doctors usually begin by looking at a patient’s history, risk factors, and symptoms. People with cirrhosis or chronic hepatitis often have regular ultrasound scans and blood tests to catch tumors early.

Several tests support the diagnosis:

  • Imaging: Contrast-enhanced CT or MRI scans show liver tumors and their features. In patients with cirrhosis, a typical imaging pattern can confirm HCC without a biopsy.
  • Blood tests: Doctors measure alpha-fetoprotein (AFP) and check liver function. However, AFP has limitations for early detection, and its levels can vary in people with non-cancerous liver disease.
  • Biopsy: A tissue sample helps when imaging results are unclear.

Doctors stage the disease using systems such as the Barcelona Clinic Liver Cancer (BCLC) classification. Staging considers tumor size, liver function, and the patient’s overall health.

Treatment of Liver Cancer

Treatment depends on the tumor stage and how well the liver is working. 

Some common options include:

  • Surgery: Doctors may remove part of the liver or perform a liver transplant for selected patients.
  • Ablation: Heat or other energy destroys small tumors.
  • Embolization: Doctors block the blood supply to the tumor. Some treatments also deliver chemotherapy or radiation directly to it.
  • Radiation therapy: Focused radiation can shrink tumors.
  • Systemic therapy: Immunotherapy combinations, such as atezolizumab with bevacizumab, and targeted drugs like lenvatinib and sorafenib help patients with advanced disease.

Because many patients also have cirrhosis, doctors must balance cancer treatment with liver safety. Care teams often include hepatologists, oncologists, surgeons, and radiologists.

Moreover, researchers continue to test new therapies. They also use Oncology Research Samples to learn why some tumors respond while others resist treatment.

Applications of Liver Cancer Samples for Research

Hepatocellular Carcinoma Serum Samples

Hepatocellular Carcinoma Serum Samples allow researchers to look for proteins, metabolites, and other molecules that rise or fall in HCC. Studies of serum from HCC patients and cirrhosis controls have used metabolomics and lipidomics to search for new biomarkers.

Human Plasma Samples

Plasma is the liquid portion of blood collected with an anticoagulant. Human Plasma Samples are useful for cell-free DNA, circulating RNA, and cytokine studies.

Human Blood Samples

Human Blood Samples support work on circulating cells and on blood-derived products. Researchers can also use them to isolate DNA or RNA.

PBMC Samples

Peripheral blood mononuclear cells (PBMCs) include lymphocytes and monocytes isolated from whole blood. Researchers use PBMC samples to study the immune response in liver cancer, including how immune cells behave in patients with HCC. When PBMCs come from the same patient as the tumor tissue, researchers can link immune findings to tumor features. 

Frequently Asked Questions

What is the difference between serum and plasma samples?

Serum comes from blood that has clotted, so it lacks clotting factors. Plasma comes from blood treated with an anticoagulant, so it keeps them. The right choice depends on the assay and the research question.

Can researchers compare liver cancer samples with healthy controls?

Yes. Researchers can compare disease samples with normal healthy donor samples to find differences in biomarkers.

Are Bay Biosciences’ human biospecimens ethically sourced?

Yes. We collect all human biospecimens through appropriate consent and IRB-approved protocols.